Search results for: 'Cell and Gene Therapeutics Market'
- Related search terms
- Cell Biology Research Market, Global, 2024–2030
- market research q1 2024
- cell biology research market
- market size of china overhead marketing industry
- market research q1 2030 ® ion 28
-
23 Aug 2019  |  Global  |  Technology Research
Emerging Therapeutics for Neurodegenerative Diseases, Part I: Novel Targeted Therapeutic Strategies Technologies for Alzheimer's and Parkinson's Diseases
Novel Targeted Therapeutic Strategies Technologies Around Neurodegenerative Disorders - From Palliative to Future Interventions
At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...
$4,950.00 -
24 Oct 2024  |  Global  |  Market Research
Evolution of EV Batteries by Cell Type (Prismatic, Pouch, Cylindrical), Forecast to 2030
Prismatic EV Batteries will Experience Transformational Growth by 2030. Pouch Cells will Gain Popularity, Driven by the Growing Adoption of Solid-state Batteries.
Global demand for electric vehicle (EV) batteries is surging, driven by the rapid growth of EVs and the increasingly stringent environmental regulations. In response, the industry is experiencing a transformative shift, with advancements in battery formats, chemistries, and structural designs. Cylindrical, prismatic, and pouch cells—each with uniqu...
$4,950.00 -
05 May 2026  |  Global  |  Market Research
Growth Opportunities in Biologics Contract Development & Manufacturing Organizations, Global, 2026–2031
Targeted ADC Upstream and Aseptic Fill-Finish Expansion Expected to Resolve Regional Capacity Gaps and Drive Bio-CDMO Growth
The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...
$2,450.00 -
23 Sep 2013  |  Asia Pacific  |  Market Research
Analysis of the Global Type 2 Diabetes Therapeutics Market
Market Opportunities for Differentiated Therapeutics
The packaging industry plays a major role in the pharmaceutical market. It not only provides containment and drug safety, but also ensures identity, convenience of handling, and delivery. It needs to balance complex considerations. Pharmaceutical packaging firms are some of the industrys most innovative companies, as has been evident in the last 1...
$10,000.00 -
11 Mar 2019  |  North America  |  Market Research
Global Cell Therapy Market—Companies to Action, 2018
A Collaborative Business Model With Focus on Stem Cells, Chimeric Antigen Receptor T (CAR-T) Cells and Combination Therapies Will Propel Market Growth
The global pharmaceutical industry is continuously evolving. with the rising need for novel therapies in the ever-changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as continuously growing number of cancer cases, market needs are shifting from traditional, small molecules to novel, large-molecule the...
$3,000.00 -
17 Aug 2022  |  Global  |  Technology Research
Therapeutic Advances in Amyloidosis
Research Efforts and Technology Developments through Partnerships and Collaborations will Push New Therapeutic Modalities into Treatment Regimens.
Amyloidosis is a rare disease caused by the accumulation and the deposition of proteins such as immunoglobulin light-chain protein in AL amyloidosis and misfolded transthyretin (TTR) protein in ATTR amyloidosis. There are a few other types of amyloidosis as well, which are either a result of a preexisting condition or are not highly prevalent. Vari...
$4,950.00 -
28 Sep 2018  |  North America  |  Technology Research
Gene Editing and Gene Therapy Breakthroughs to Propel Mainstream Disease Treatments
A new wave of gene therapies is set to revolutionize treatments over the next decade for inherited diseases which are either untreatable or which do not have a satisfactory treatment outcome at present
The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...
$4,950.00 -
18 Dec 2023  |  North America  |  Market Research
Fuel Cell Commercial Vehicle Growth Opportunities Light, Medium, and Heavy-duty Trucks
Fuel Cell Trucks as an Additional Powertrain Strategy for Specific Segments and Green Hydrogen Adoption
Electrification in trucking is gaining momentum as a Mega Trend, with new mobility models shaping the industry s future. Various sub-trends within electric vehicles (EVs), such as battery EVs (BEVs) and FCEVs, are increasingly popular as emission norms become stricter and the focus on achieving cleaner forms of goods transportation is higher. The p...
$4,950.00 -
19 Jan 2018  |  North America  |  Market Research
The Global Immuno-oncology Therapeutics Market—Adoptive T-cell Therapies, Forecast to 2022
The Next Generation of Cancer Therapies
Immuno-oncology refers to drugs that are used to stimulate the human immune system to target the fight against cancer. The immune system is capable of recognizing and eliminating foreign substances, including tumor cells. Tumors have, however, been able to escape detection by the immune system. There are drugs that can empower the immune system cel...
$3,000.00 -
17 Sep 2019  |  Global  |  Technology Research
Emerging Therapeutics for Neurodegenerative Diseases Part II: Huntington's Disease and Amyotrophic Lateral Sclerosis (HD & ALS)
Novel Targeted Therapeutic Strategies Technologies Around Neurodegenerative Disorders - From Palliative to Future Interventions
At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...
$4,950.00